Bioaffinity Technologies Inc (BIAF)

$1.07 -0.20 (-15.75%)
Market Cap 5.13M
Revenue (ttm) 9.36M
Net Income (ttm) -9.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -96.58%
Debt to Equity Ratio 0.02
Volume 113,291
Avg Vol 82,672
Day's Range N/A - N/A
Shares Out 4.50M
Stochastic %K 63%
Beta 2.45
Analysts Strong Buy
Price Target $6.00

Company Profile

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, incl...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 210 698 5334
Address:
3300 Nacogdoches Road, Suite 216, San Antonio, United States
CedarFence
CedarFence Feb. 3 at 4:15 PM
$BIAF Yep! That’s great news. Now… let’s use it. The purpose of a patent is to prevent others from making or selling an invention so as to allow the patent holder to PROFIT FROM THE INVENTION.
0 · Reply
artmas92
artmas92 Feb. 3 at 3:14 PM
$BIAF Patent is real, issued today, and verifiable on https://ppubs.uspto.gov/basic/ Search for patent 12,542,215 👍
0 · Reply
WenABVEAudit
WenABVEAudit Feb. 3 at 2:34 PM
$BIAF gotta be kidding me. Good patent news and they drop this like a rock at open?
1 · Reply
M1Tanker
M1Tanker Feb. 2 at 9:51 PM
$BIAF
0 · Reply
M1Tanker
M1Tanker Feb. 2 at 9:24 PM
$BIAF 🙏
1 · Reply
Stonecrest
Stonecrest Feb. 2 at 9:23 PM
$BIAF Why is it down so much in AH? I know AH doesn’t mean a lot but damn it was good news. Who in the hell would sell at that price?
1 · Reply
artmas92
artmas92 Feb. 2 at 9:23 PM
$BIAF Sleeping giant
0 · Reply
M1Tanker
M1Tanker Feb. 2 at 9:17 PM
$BIAF added 1.09
0 · Reply
MakeM0ney_444
MakeM0ney_444 Feb. 2 at 9:04 PM
$BIAF what the hell
0 · Reply
MakeM0ney_444
MakeM0ney_444 Feb. 2 at 9:02 PM
$BIAF will this patent help secure a buyout?
0 · Reply
Latest News on BIAF
bioAffinity Technologies' Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation

Jan 7, 2026, 8:00 AM EST - 27 days ago

bioAffinity Technologies' Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation

bioAffinity Technologies' Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable

Dec 3, 2025, 8:00 AM EST - 2 months ago

bioAffinity Technologies' Noninvasive CyPath® Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable

bioAffinity Technologies Reports Third Quarter 2025 Financial Results

Nov 14, 2025, 8:00 AM EST - 2 months ago

bioAffinity Technologies Reports Third Quarter 2025 Financial Results

bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume

Nov 5, 2025, 8:00 AM EST - 3 months ago

bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

Oct 28, 2025, 8:00 AM EDT - 3 months ago

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025

Oct 20, 2025, 8:00 AM EDT - 3 months ago

bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025

bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer

Oct 16, 2025, 8:00 AM EDT - 3 months ago

bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer

bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements

Oct 15, 2025, 8:00 AM EDT - 3 months ago

bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements

WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 9, 2025, 2:00 PM EDT - 4 months ago

WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 9, 2025, 1:00 PM EDT - 4 months ago

bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 8, 2025, 4:15 PM EDT - 4 months ago

WallachBeth Capital Announces bioAffinity Technologies Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

Oct 8, 2025, 3:45 PM EDT - 4 months ago

bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025

Oct 7, 2025, 8:00 AM EDT - 4 months ago

bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025

WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m

Sep 30, 2025, 12:44 PM EDT - 4 months ago

WallachBeth Capital Announces Closing of bioAffinity Technologies Public Offering for $4.8m

bioAffinity Technologies Announces Closing of $4.8 Million Public Offering

Sep 30, 2025, 12:15 PM EDT - 4 months ago

bioAffinity Technologies Announces Closing of $4.8 Million Public Offering

WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m

Sep 29, 2025, 5:59 PM EDT - 4 months ago

WallachBeth Capital Announces Pricing of bioAffinity Technologies Public Offering for $4.8m

bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering

Sep 29, 2025, 3:51 PM EDT - 4 months ago

bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering

bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung

Sep 26, 2025, 8:00 AM EDT - 4 months ago

bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung

bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025

Sep 17, 2025, 8:15 AM EDT - 4 months ago

bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025

Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules

Sep 9, 2025, 8:00 AM EDT - 5 months ago

Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules

bioAffinity Technologies Appoints New Members to Board of Directors

Aug 18, 2025, 8:00 AM EDT - 6 months ago

bioAffinity Technologies Appoints New Members to Board of Directors

bioAffinity Technologies Announces Closing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds

Aug 14, 2025, 4:15 PM EDT - 6 months ago

bioAffinity Technologies Announces Closing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds

bioAffinity Technologies Reports Second Quarter 2025 Results

Aug 14, 2025, 8:00 AM EDT - 6 months ago

bioAffinity Technologies Reports Second Quarter 2025 Results

bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds

Aug 13, 2025, 9:25 AM EDT - 6 months ago

bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds

bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales

Aug 13, 2025, 8:00 AM EDT - 6 months ago

bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales

Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient With Inconclusive Imaging and Low-Risk Serum Test Results

Jul 29, 2025, 8:00 AM EDT - 6 months ago

Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient With Inconclusive Imaging and Low-Risk Serum Test Results

Canada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company's Noninvasive Lung Cancer Diagnostic

Jul 22, 2025, 9:00 AM EDT - 7 months ago

Canada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company's Noninvasive Lung Cancer Diagnostic

bioAffinity Technologies Announces Notification of China Patent Award for Company's Noninvasive Lung Cancer Diagnostic

Jul 15, 2025, 9:00 AM EDT - 7 months ago

bioAffinity Technologies Announces Notification of China Patent Award for Company's Noninvasive Lung Cancer Diagnostic

bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference

Jun 26, 2025, 9:00 AM EDT - 7 months ago

bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference

bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy

Jun 24, 2025, 9:00 AM EDT - 8 months ago

bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy

bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas' Leadership Board

Jun 11, 2025, 9:00 AM EDT - 8 months ago

bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas' Leadership Board

bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics

May 28, 2025, 9:00 AM EDT - 8 months ago

bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics

bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer

May 20, 2025, 9:00 AM EDT - 9 months ago

bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer

bioAffinity Technologies Reports First Quarter 2025 Results

May 15, 2025, 8:30 AM EDT - 9 months ago

bioAffinity Technologies Reports First Quarter 2025 Results

Independent White Paper Highlights Real-World Impact of bioAffinity Technologies' CyPath® Lung in Diagnosing Early-Stage Lung Cancer

May 8, 2025, 9:00 AM EDT - 9 months ago

Independent White Paper Highlights Real-World Impact of bioAffinity Technologies' CyPath® Lung in Diagnosing Early-Stage Lung Cancer

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.25m Offering

May 7, 2025, 1:15 PM EDT - 9 months ago

WallachBeth Capital Announces Closing of bioAffinity Technologies $3.25m Offering

bioAffinity Technologies Announces Closing of $3.25 Million Offering

May 7, 2025, 1:00 PM EDT - 9 months ago

bioAffinity Technologies Announces Closing of $3.25 Million Offering

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.25m Offering

May 6, 2025, 10:30 AM EDT - 9 months ago

WallachBeth Capital Announces Pricing of bioAffinity Technologies $3.25m Offering

bioAffinity Technologies Announces Pricing of $3.25 Million Offering

May 6, 2025, 9:25 AM EDT - 9 months ago

bioAffinity Technologies Announces Pricing of $3.25 Million Offering

bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost

Apr 17, 2025, 9:15 AM EDT - 10 months ago

bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost

bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024

Mar 31, 2025, 9:28 AM EDT - 11 months ago

bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024

Case Study: bioAffinity Technologies' CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer

Mar 26, 2025, 9:00 AM EDT - 11 months ago

Case Study: bioAffinity Technologies' CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer

Case Study: bioAffinity Technologies' Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence

Mar 19, 2025, 9:00 AM EDT - 11 months ago

Case Study: bioAffinity Technologies' Positive CyPath® Lung Result Leads to Detecting Breast Cancer Recurrence

Physicians' Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer

Mar 13, 2025, 9:00 AM EDT - 11 months ago

Physicians' Case Studies Offer Insight into Use and Benefit of CyPath® Lung in Avoiding Unnecessary Invasive Procedures and Detecting Lung Cancer

bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth

Mar 6, 2025, 8:00 AM EST - 11 months ago

bioAffinity Technologies Announces Targeted Actions to Cut $4 Million in Costs and Drive CyPath® Lung Sales Growth

WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million

Feb 26, 2025, 12:10 PM EST - 1 year ago

WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million

bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million

Feb 26, 2025, 11:30 AM EST - 1 year ago

bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million

WallachBeth Capital Announces bioAffinity Technologies Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million

Feb 25, 2025, 11:05 AM EST - 1 year ago

WallachBeth Capital Announces bioAffinity Technologies Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million

bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million

Feb 25, 2025, 9:58 AM EST - 1 year ago

bioAffinity Technologies Announces Warrant Inducement for Aggregate Gross Proceeds of $1.4 Million

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic

Jan 22, 2025, 8:00 AM EST - 1 year ago

bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic

CedarFence
CedarFence Feb. 3 at 4:15 PM
$BIAF Yep! That’s great news. Now… let’s use it. The purpose of a patent is to prevent others from making or selling an invention so as to allow the patent holder to PROFIT FROM THE INVENTION.
0 · Reply
artmas92
artmas92 Feb. 3 at 3:14 PM
$BIAF Patent is real, issued today, and verifiable on https://ppubs.uspto.gov/basic/ Search for patent 12,542,215 👍
0 · Reply
WenABVEAudit
WenABVEAudit Feb. 3 at 2:34 PM
$BIAF gotta be kidding me. Good patent news and they drop this like a rock at open?
1 · Reply
M1Tanker
M1Tanker Feb. 2 at 9:51 PM
$BIAF
0 · Reply
M1Tanker
M1Tanker Feb. 2 at 9:24 PM
$BIAF 🙏
1 · Reply
Stonecrest
Stonecrest Feb. 2 at 9:23 PM
$BIAF Why is it down so much in AH? I know AH doesn’t mean a lot but damn it was good news. Who in the hell would sell at that price?
1 · Reply
artmas92
artmas92 Feb. 2 at 9:23 PM
$BIAF Sleeping giant
0 · Reply
M1Tanker
M1Tanker Feb. 2 at 9:17 PM
$BIAF added 1.09
0 · Reply
MakeM0ney_444
MakeM0ney_444 Feb. 2 at 9:04 PM
$BIAF what the hell
0 · Reply
MakeM0ney_444
MakeM0ney_444 Feb. 2 at 9:02 PM
$BIAF will this patent help secure a buyout?
0 · Reply
AlertsAndNews
AlertsAndNews Feb. 2 at 9:01 PM
$BIAF patent news into the close here. been a while since we've seen a patent pop.
0 · Reply
MakeM0ney_444
MakeM0ney_444 Feb. 2 at 9:00 PM
$BIAF HEY NOW
0 · Reply
MakeM0ney_444
MakeM0ney_444 Feb. 2 at 8:59 PM
$BIAF wtf was that 👀👀👀
0 · Reply
Quagglerock
Quagglerock Feb. 2 at 8:59 PM
$BIAF Hmmm…
0 · Reply
PatentGrants
PatentGrants Feb. 2 at 8:56 PM
$BIAF bioAffinity Technologies will be issued US patent number 12,542,215 tomorrow titled "DETECTION OF EARLY-STAGE LUNG CANCER IN SPUTUM USING AUTOMATED FLOW CYTOMETRY AND MACHINE LEARNING". https://patentcenter.uspto.gov/applications/18745375/ifw/docs
0 · Reply
CedarFence
CedarFence Feb. 2 at 5:26 PM
$BIAF Well, yesterday I said they’ll either scale up or get absorbed. I have a feeling I know which one it will be. Some company will pick up the fumble with CyPath and the other programs they have going. The contracts and patents will practically cover themselves. Just my opinion, of course.
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Feb. 2 at 4:43 PM
$BIAF Let's refer to them as "easily solvable Start-Up Problems".
0 · Reply
Stonecrest
Stonecrest Feb. 2 at 4:02 PM
$BIAF How long until they have to do another reverse split. I own way too much of this shit. I doubt they have enough money to make it long.
0 · Reply
Pettersen
Pettersen Jan. 31 at 8:30 AM
$BIAF Buckle up boys. I sold my shares yesterday. I did the same mistake on BNAI. If i head them to the end i would be drinking beer on a big plate and sheerpas would carry me on mountens. The stocks usualy blows up when i go out. I sold ELPW early also. Strap on seatbelts
1 · Reply
GJ_Rockabilt
GJ_Rockabilt Jan. 30 at 2:06 PM
$BIAF Hello, Fam. Today is last day to sign up for FREE Warrants with every Share of Cancer fighting $TPST . Acquisition in process. Do your own Due Diligence.
0 · Reply
CedarFence
CedarFence Jan. 28 at 9:36 PM
$BIAF $BIAF I wish this stock could get some traction. The company is absolutely changing how lung cancer is discovered. Their process has identified lung cancers at the very earliest stages. Read their research and be amazed. I’m waiting for some “dry powder” to buy more. Just my opinion - do your own research.
1 · Reply
Hotresearchsgoldenage
Hotresearchsgoldenage Jan. 26 at 1:24 AM
$BIAF anyone with think or swim getting this message?
2 · Reply